Loading the section
Company reports as filed with the U.S. Securities and Exchange Commission.
| Metric | Mar 31, 2026 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Sep 30, 2024 | Jun 30, 2024 |
|---|---|---|---|---|---|---|
| Revenue | 13.20bn | 13.47bn | 12.65bn | 11.53bn | 11.19bn | 10.70bn |
| Cost of revenue | 7.26bn | 8.11bn | 7.61bn | 6.94bn | 6.76bn | 6.49bn |
| Research and development | 951m | 862m | 840m | 815m | 774m | 760m |
| Selling, general and administrative | 798m | 1.18bn | 669m | 657m | 630m | 686m |
| Operating expenses | 11.28bn | 12.35bn | 11.20bn | 10.31bn | 10.13bn | 9.90bn |
| Operating income | 1.92bn | 1.11bn | 1.45bn | 1.23bn | 1.06bn | 796m |
| Pre-tax income | 496m | 2.62bn | 1.50bn | 1.39bn | 2.77bn | 1.08bn |
| Income tax | 194m | −4.05bn | 142m | −402m | 158m | 57m |
| Net income | 263m | 6.63bn | 1.36bn | 1.78bn | 2.61bn | 1.02bn |
| Earnings per share | 0.13 | 3.18 | 0.65 | 0.85 | 1.24 | 0.49 |
| Earnings per share, diluted | 0.13 | 3.11 | 0.63 | 0.83 | 1.20 | 0.47 |
| Weighted average shares | 2.05bn | 2.08bn | 2.09bn | 2.09bn | 2.10bn | 2.09bn |
| Weighted average shares, diluted | 2.07bn | 2.12bn | 2.13bn | 2.12bn | 2.15bn | 2.15bn |
| Metric | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 5.56bn | 7.11bn | 8.43bn | 6.44bn | 5.13bn | 5.89bn | 6.15bn | 4.50bn |
| Short-term investments | 533m | 528m |
| Metric | Mar 31, 2026 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Sep 30, 2024 | Jun 30, 2024 |
|---|---|---|---|---|---|---|
| Operating cash flow | 2.35bn | — | — | 2.32bn | — | — |
| Depreciation and amortisation | 184m | 188m | 175m | 171m |
Amounts in USD unless stated otherwise. Sources: Nasdaq Trader, Yahoo Finance, U.S. Securities and Exchange Commission (EDGAR)
| 654m |
| 932m |
| 894m |
| 1.08bn |
| 2.91bn |
| 1.80bn |
| Receivables | 3.90bn | 3.83bn | 3.77bn | 3.77bn | 3.49bn | 3.33bn | 3.72bn | 3.78bn |
| Current assets | 12.82bn | 13.99bn | 15.14bn | 14.11bn | 12.35bn | 12.25bn | 15.33bn | 12.48bn |
| Property, plant and equipment | — | — | — | — | — | — | 1.98bn | 2.03bn |
| Goodwill | 8.92bn | 8.93bn | 8.92bn | 8.91bn | 8.07bn | 8.07bn | 8.09bn | 8.08bn |
| Total assets | 59.89bn | 61.80bn | 63.34bn | 55.98bn | 52.82bn | 51.24bn | 47.12bn | 41.51bn |
| Current liabilities | 11.99bn | 12.32bn | 13.12bn | 12.69bn | 12.11bn | 11.48bn | 10.84bn | 10.32bn |
| Long-term debt | 10.51bn | 10.52bn | 10.62bn | 9.58bn | 8.35bn | 8.35bn | 10.99bn | 9.45bn |
| Total liabilities | 34.07bn | 33.72bn | 34.19bn | 32.35bn | 29.92bn | 28.77bn | 30.58bn | 27.73bn |
| Equity | 24.75bn | 27.04bn | 28.13bn | 23.45bn | 22.81bn | 21.56bn | 15.59bn | 13.15bn |
| Shares outstanding | 2.04bn | 2.07bn | 2.08bn | 2.09bn | 2.09bn | 2.11bn | 2.10bn | 2.10bn |
| Shares issued | 2.04bn | 2.07bn | 2.08bn | 2.09bn | 2.09bn | 2.11bn | 2.10bn | 2.10bn |
| 179m |
| 173m |
| Share-based compensation | 473m | — | — | 435m | — | — |
| Capital expenditure | 65m | — | — | 74m | — | — |
| Investing cash flow | −773m | — | — | −542m | — | — |
| Share buybacks | 3.01bn | — | — | 1.79bn | — | — |
| Financing cash flow | −3.09bn | — | — | −1.86bn | — | — |